The latest report pertaining to 'Monoclonal Antibodies Market provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
In 2019, the market size of Monoclonal Antibodies is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Monoclonal Antibodies.
This report studies the global market size of Monoclonal Antibodies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Monoclonal Antibodies sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
Roche
Johnson & Johnson
Amgen
Merck
BMS
Eli Lilly
Formation Biologics
Genmab
GlaxoSmithKline
Human Genome Sciences
mmunogen
MedImmune
Novartis
Pfizer
Seattle Genetics
Stemcentrx
Synthon Biopharmaceuticals
Takeda
Teva
Market Segment by Product Type
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others
Market Segment by Application
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Monoclonal Antibodies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Monoclonal Antibodies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Monoclonal Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Interested in this report?
Get your sample now!
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Type (2019-2025)
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Monoclonal Antibodies Market Share by Application (2019-2025)
1.4.2 Oncology
1.4.3 Autoimmune and inflammatory diseases
1.4.4 Respiratory diseases
1.4.5 Ophthalmology
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibodies Market Size
2.1.1 Global Monoclonal Antibodies Revenue 2014-2025
2.1.2 Global Monoclonal Antibodies Sales 2014-2025
2.2 Monoclonal Antibodies Growth Rate by Regions
2.2.1 Global Monoclonal Antibodies Sales by Regions 2014-2019
2.2.2 Global Monoclonal Antibodies Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Monoclonal Antibodies Sales by Manufacturers
3.1.1 Monoclonal Antibodies Sales by Manufacturers 2014-2019
3.1.2 Monoclonal Antibodies Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Monoclonal Antibodies Revenue by Manufacturers (2014-2019)
3.2.2 Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.3 Monoclonal Antibodies Price by Manufacturers
3.4 Key Manufacturers Monoclonal Antibodies Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Monoclonal Antibodies Market
3.6 Key Manufacturers Monoclonal Antibodies Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Cancer Sales and Revenue (2014-2019)
4.1.2 Autoimmune Diseases Sales and Revenue (2014-2019)
4.1.3 Infection Sales and Revenue (2014-2019)
4.1.4 Hematological Diseases Sales and Revenue (2014-2019)
4.1.5 Others Sales and Revenue (2014-2019)
4.2 Global Monoclonal Antibodies Sales Market Share by Type
4.3 Global Monoclonal Antibodies Revenue Market Share by Type
4.4 Monoclonal Antibodies Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Monoclonal Antibodies Sales by Application
6 United States
6.1 United States Monoclonal Antibodies Breakdown Data by Company
6.2 United States Monoclonal Antibodies Breakdown Data by Type
6.3 United States Monoclonal Antibodies Breakdown Data by Application
7 European Union
7.1 European Union Monoclonal Antibodies Breakdown Data by Company
7.2 European Union Monoclonal Antibodies Breakdown Data by Type
7.3 European Union Monoclonal Antibodies Breakdown Data by Application
8 China
8.1 China Monoclonal Antibodies Breakdown Data by Company
8.2 China Monoclonal Antibodies Breakdown Data by Type
8.3 China Monoclonal Antibodies Breakdown Data by Application
9 Rest of World
9.1 Rest of World Monoclonal Antibodies Breakdown Data by Company
9.2 Rest of World Monoclonal Antibodies Breakdown Data by Type
9.3 Rest of World Monoclonal Antibodies Breakdown Data by Application
9.4 Rest of World Monoclonal Antibodies Breakdown Data by Countries
9.4.1 Rest of World Monoclonal Antibodies Sales by Countries
9.4.2 Rest of World Monoclonal Antibodies Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.1.4 Monoclonal Antibodies Product Introduction
10.1.5 AbbVie Recent Development
10.2 Roche
10.2.1 Roche Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.2.4 Monoclonal Antibodies Product Introduction
10.2.5 Roche Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.3.4 Monoclonal Antibodies Product Introduction
10.3.5 Johnson & Johnson Recent Development
10.4 Amgen
10.4.1 Amgen Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.4.4 Monoclonal Antibodies Product Introduction
10.4.5 Amgen Recent Development
10.5 Merck
10.5.1 Merck Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.5.4 Monoclonal Antibodies Product Introduction
10.5.5 Merck Recent Development
10.6 BMS
10.6.1 BMS Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.6.4 Monoclonal Antibodies Product Introduction
10.6.5 BMS Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.7.4 Monoclonal Antibodies Product Introduction
10.7.5 Eli Lilly Recent Development
10.8 Formation Biologics
10.8.1 Formation Biologics Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.8.4 Monoclonal Antibodies Product Introduction
10.8.5 Formation Biologics Recent Development
10.9 Genmab
10.9.1 Genmab Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.9.4 Monoclonal Antibodies Product Introduction
10.9.5 Genmab Recent Development
10.10 GlaxoSmithKline
10.10.1 GlaxoSmithKline Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Monoclonal Antibodies
10.10.4 Monoclonal Antibodies Product Introduction
10.10.5 GlaxoSmithKline Recent Development
10.11 Human Genome Sciences
10.12 mmunogen
10.13 MedImmune
10.14 Novartis
10.15 Pfizer
10.16 Seattle Genetics
10.17 Stemcentrx
10.18 Synthon Biopharmaceuticals
10.19 Takeda
10.20 Teva
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Monoclonal Antibodies Sales Channels
11.2.2 Monoclonal Antibodies Distributors
11.3 Monoclonal Antibodies Customers
12 Market Forecast
12.1 Global Monoclonal Antibodies Sales and Revenue Forecast 2019-2025
12.2 Global Monoclonal Antibodies Sales Forecast by Type
12.3 Global Monoclonal Antibodies Sales Forecast by Application
12.4 Monoclonal Antibodies Forecast by Regions
12.4.1 Global Monoclonal Antibodies Sales Forecast by Regions 2019-2025
12.4.2 Global Monoclonal Antibodies Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Monoclonal Antibodies Product Picture
Table Monoclonal Antibodies Key Market Segments
Table Major Manufacturers Monoclonal Antibodies Covered in This Report
Table Global Monoclonal Antibodies Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Monoclonal Antibodies Sales Market Shar by Type 2014-2025
Figure Cancer Figures
Table Major Manufacturers of Cancer
Figure Autoimmune Diseases Figures
Table Major Manufacturers of Autoimmune Diseases
Figure Infection Figures
Table Major Manufacturers of Infection
Figure Hematological Diseases Figures
Table Major Manufacturers of Hematological Diseases
Figure Others Figures
Table Major Manufacturers of Others
Table Global Monoclonal Antibodies Market Share by Application 2019-2025 (MT)
Figure Oncology Use Case
Figure Autoimmune and inflammatory diseases Use Case
Figure Respiratory diseases Use Case
Figure Ophthalmology Use Case
Figure Monoclonal Antibodies Report Years Considered
Figure Global Monoclonal Antibodies Market Size 2014-2025 (Million US$)
Figure Global Monoclonal Antibodies Sales 2014-2019 (MT)
Table Global Monoclonal Antibodies Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Monoclonal Antibodies Sales by Regions 2014-2019 (MT)
Table Global Monoclonal Antibodies Sales Market Share by Regions 2014-2019
Figure Global Monoclonal Antibodies Sales Market Share by Regions 2014-2019
Figure Global Monoclonal Antibodies Sales Market Share by Regions in 2019
Table Global Monoclonal Antibodies Revenue by Regions 2014-2019 (Million US$)
Table Global Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
Figure Global Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
Figure Global Monoclonal Antibodies Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Monoclonal Antibodies Sales by Manufacturers (2014-2019) (MT)
Table Global Monoclonal Antibodies Sales Share by Manufacturers (2014-2019)
Figure Global Monoclonal Antibodies Sales Share by Manufacturers in 2019
Table Monoclonal Antibodies Revenue by Manufacturers (2014-2019) (Million USD)
Table Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
Figure Monoclonal Antibodies Value Share by Manufacturers in 2019
Table Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Monoclonal Antibodies Price (2014-2019) (USD/Kg)
Table Key Manufacturers Monoclonal Antibodies Plants/Factories Distribution
Table Key Manufacturers Monoclonal Antibodies Area Served
Table Date of Key Manufacturers Enter into Monoclonal Antibodies Market
Table Key Manufacturers Monoclonal Antibodies Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Sales and Revenue (2014-2019) (MT) & (Million US$)
Table Global Autoimmune Diseases Sales and Revenue (2014-2019) (MT) & (Million US$)
Table Global Infection Sales and Revenue (2014-2019) (MT) & (Million US$)
Table Global Hematological Diseases Sales and Revenue (2014-2019) (MT) & (Million US$)
Table Global Others Sales and Revenue (2014-2019) (MT) & (Million US$)
Table Global Monoclonal Antibodies Sales by Type (2014-2019) (MT)
Table Global Monoclonal Antibodies Sales Share by Type (2014-2019)
Figure Global Monoclonal Antibodies Sales Market Share by Type (2014-2019)
Figure Global Monoclonal Antibodies Sales Market Share by Type in 2018
Table Global Monoclonal Antibodies Revenue by Type (2014-2019) (Million US$)
Table Global Monoclonal Antibodies Revenue Share by Type (2014-2019)
Figure Global Monoclonal Antibodies Revenue Market Share by Type (2014-2019)
Figure Global Monoclonal Antibodies Revenue Market Share by Type in 2018
Table Monoclonal Antibodies Price by Type 2014-2019 (USD/Kg)
Table Global Monoclonal Antibodies Sales by Application (2014-2019) (MT)
Table Global Monoclonal Antibodies Sales Share by Application (2014-2019)
Figure Global Sales Monoclonal Antibodies Market Share by Application (2014-2019)
Figure Global Sales Monoclonal Antibodies Market Share by Application (2014-2019)
Figure United States Monoclonal Antibodies Sales Growth Rate 2014-2019 (MT)
Figure United States Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table United States Monoclonal Antibodies Sales by Company (2014-2019) (MT)
Table United States Monoclonal Antibodies Sales Market Share by Company (2014-2019)
Figure United States Monoclonal Antibodies Sales Market Share by Company in 2019
Table United States Monoclonal Antibodies Sales by Type (2014-2019) (MT)
Table United States Monoclonal Antibodies Sales Market Share by Type (2014-2019)
Figure United States Monoclonal Antibodies Market Share by Type in 2019
Table United States Monoclonal Antibodies Sales by Application (2014-2019) (MT)
Table United States Monoclonal Antibodies Sales Market Share by Application (2014-2019)
Figure United States Monoclonal Antibodies Market Share by Application in 2019
Figure European Union Monoclonal Antibodies Sales Growth Rate 2014-2019 (MT)
Figure European Union Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Monoclonal Antibodies Sales by Company (2014-2019) (MT)
Table European Union Monoclonal Antibodies Sales Market Share by Company (2014-2019)
Figure European Union Monoclonal Antibodies Sales Market Share by Company in 2019
Table European Union Monoclonal Antibodies Sales by Type (2014-2019) (MT)
Table European Union Monoclonal Antibodies Sales Market Share by Type (2014-2019)
Figure 2018 European Union Monoclonal Antibodies Market Share by Type
Table European Union Monoclonal Antibodies Sales by Application (2014-2019) (MT)
Table European Union Monoclonal Antibodies Sales Market Share by Application (2014-2019)
Figure 2018 European Union Monoclonal Antibodies Market Share by Application
Figure China Monoclonal Antibodies Sales Growth Rate 2014-2019 (MT)
Figure China Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table China Monoclonal Antibodies Sales by Company (2014-2019) (MT)
Table China Monoclonal Antibodies Sales Market Share by Company (2014-2019)
Figure China Monoclonal Antibodies Sales Market Share by Company in 2019
Table China Monoclonal Antibodies Sales by Type (2014-2019) (MT)
Table China Monoclonal Antibodies Sales Market Share by Type (2014-2019)
Figure China Monoclonal Antibodies Market Share by Type in 2019
Table China Monoclonal Antibodies Sales by Application (2014-2019) (MT)
Table China Monoclonal Antibodies Sales Market Share by Application (2014-2019)
Figure China Monoclonal Antibodies Market Share by Application in 2019
Figure Rest of World Monoclonal Antibodies Sales Growth Rate 2014-2019 (MT)
Figure Rest of World Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Monoclonal Antibodies Sales by Company (2014-2019) (MT)
Table Rest of World Monoclonal Antibodies Sales Market Share by Company (2014-2019)
Figure Rest of World Monoclonal Antibodies Sales Market Share by Company in 2019
Table Rest of World Monoclonal Antibodies Sales by Type (2014-2019) (MT)
Table Rest of World Monoclonal Antibodies Sales Market Share by Type (2014-2019)
Figure Rest of World Monoclonal Antibodies Market Share by Type in 2019
Table Rest of World Monoclonal Antibodies Sales by Application (2014-2019) (MT)
Table Rest of World Monoclonal Antibodies Sales Market Share by Application (2014-2019)
Figure Rest of World Monoclonal Antibodies Market Share by Application in 2019
Table Rest of World Monoclonal Antibodies Sales by Countries (2014-2019) (MT)
Table Rest of World Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
Figure Rest of World Monoclonal Antibodies Sales Market Share by Countries in 2019
Table Rest of World Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
Figure Rest of World Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure Japan Monoclonal Antibodies Sales Growth Rate (2014-2019) (MT)
Figure Japan Monoclonal Antibodies Revenue Growth Rate (2014-2019) (MT)
Figure Korea Monoclonal Antibodies Sales Growth Rate (2014-2019) (MT)
Figure Korea Monoclonal Antibodies Revenue Growth Rate (2014-2019) (MT)
Figure India Monoclonal Antibodies Sales Growth Rate (2014-2019) (MT)
Figure India Monoclonal Antibodies Revenue Growth Rate (2014-2019) (MT)
Figure Southeast Asia Monoclonal Antibodies Sales Growth Rate (2014-2019) (MT)
Figure Southeast Asia Monoclonal Antibodies Revenue Growth Rate (2014-2019) (MT)
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table AbbVie Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table AbbVie Monoclonal Antibodies Sales Market Share in Global Market
Table AbbVie Recent Development
Table Roche Company Details
Table Roche Description and Business Overview
Table Roche Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Roche Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Roche Monoclonal Antibodies Sales Market Share in Global Market
Table Roche Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Johnson & Johnson Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Johnson & Johnson Monoclonal Antibodies Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Amgen Company Details
Table Amgen Description and Business Overview
Table Amgen Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Amgen Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Amgen Monoclonal Antibodies Sales Market Share in Global Market
Table Amgen Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Merck Monoclonal Antibodies Sales Market Share in Global Market
Table Merck Recent Development
Table BMS Company Details
Table BMS Description and Business Overview
Table BMS Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table BMS Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table BMS Monoclonal Antibodies Sales Market Share in Global Market
Table BMS Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Description and Business Overview
Table Eli Lilly Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Eli Lilly Monoclonal Antibodies Sales Market Share in Global Market
Table Eli Lilly Recent Development
Table Formation Biologics Company Details
Table Formation Biologics Description and Business Overview
Table Formation Biologics Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Formation Biologics Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Formation Biologics Monoclonal Antibodies Sales Market Share in Global Market
Table Formation Biologics Recent Development
Table Genmab Company Details
Table Genmab Description and Business Overview
Table Genmab Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Genmab Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table Genmab Monoclonal Antibodies Sales Market Share in Global Market
Table Genmab Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Monoclonal Antibodies Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline Monoclonal Antibodies Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Monoclonal Antibodies Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Human Genome Sciences Company Details
Table mmunogen Company Details
Table MedImmune Company Details
Table Novartis Company Details
Table Pfizer Company Details
Table Seattle Genetics Company Details
Table Stemcentrx Company Details
Table Synthon Biopharmaceuticals Company Details
Table Takeda Company Details
Table Teva Company Details
Figure Monoclonal Antibodies Value Chain
Table Monoclonal Antibodies Distributors List
Table Monoclonal Antibodies Customers List
Table Global Monoclonal Antibodies Sales Forecast 2019-2025 (MT) & (Million US$)
Figure Global Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure Global Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Table Global Monoclonal Antibodies Sales Forecast by Type 2019-2025 (MT)
Figure Global Monoclonal Antibodies Sales Forecast by Type 2019-2025 (MT)
Figure Global Monoclonal Antibodies Sales Market Share Forecast by Type 2019-2025
Table Global Monoclonal Antibodies Sales Forecast by Application 2019-2025 (MT)
Figure Global Monoclonal Antibodies Sales Forecast by Application 2019-2025 (MT)
Figure Global Monoclonal Antibodies Sales Market Share Forecast by Application 2019-2025
Table Global Monoclonal Antibodies Sales Forecast by Regions 2019-2025 (MT)
Figure Global Monoclonal Antibodies Sales Forecast by Regions 2019-2025 (MT)
Figure Global Monoclonal Antibodies Sales Market Share Forecast by Regions 2019-2025
Table Global Monoclonal Antibodies Revenue Forecast by Regions 2019-2025 (MT)
Figure Global Monoclonal Antibodies Revenue Forecast by Regions 2019-2025 (MT)
Figure Global Monoclonal Antibodies Revenue Market Share Forecast by Regions 2019-2025
Figure United States Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure United States Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Figure European Union Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure European Union Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Figure China Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure China Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Figure Japan Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure Japan Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Figure Korea Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure Korea Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Figure India Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure India Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Monoclonal Antibodies Sales Forecast 2019-2025 (MT)
Figure Southeast Asia Monoclonal Antibodies Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
